Your search results

Complete Vitamin D solution for the diagnosis and management of phosphorus and calcium metabolism pathologies. 25OH vitamin D is recognized as a prohormone, which has multiple roles in maintaining optimal health while the active form 1,25OH vitamin D is recommended in therapeutic regimens for chronic kidney disease patient.

As a worldwide diagnostic leader in bone and mineral metabolism, Diasorin offers a comprehensive range of immunoassays for the management of bone and calcium metabolism related diseases. The immunoassays 1 - 84 PTH,  N-TACT PTH, BAP OSTASE, OSTEOCALCIN, FGF 23 round out the Vitamin D Solution.

Chronic pancreatitis can cause maldigestion.  Measuring Pancreatic elastase 1 or fecal elastase 1 (FE-1) in feces allows this condition to be assessed.

Helicobacter pylori is the causative agent of chronic gastritis or inflammation of the stomach lining, duodenal and stomach ulcers, and is associated with an increased risk of stomach cancer. 
Diasorin provides a complete diagnostic solution that include 2 CLIA assays for the detection of antigen and for antibodies for H. pylori.

C. difficile is a major cause of antibiotic-associated diarrhea and colitis. It is the causative agent for most cases of pseudomembranous colitis. These combined tests enable the rapid and efficient diagnosis of Clostridium difficile (C. difficile) infection. DiaSorin’s LIAISON^® C. Difficile Diagnostic Solution provides accurate and timely detection of C. difficile infection, improving patient outcomes and reducing healthcare costs.

The LIAISON^® Calprotectin assay can be used as an aid in the diagnosis of inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis, and as an aid in the differentiation of IBD from irritable bowel syndrome (IBS).

Helicobacter pylori is the causative agent of chronic gastritis or inflammation of the stomach lining, duodenal and stomach ulcers, and is associated with an increased risk of stomach cancer. 
Diasorin provides a complete diagnostic solution that include 2 CLIA assays for the detection of antigen and for antibodies for H. pylori.

C. difficile is a major cause of antibiotic-associated diarrhea and colitis. It is the causative agent for most cases of pseudomembranous colitis. These combined tests enable the rapid and efficient diagnosis of Clostridium difficile (C. difficile) infection. DiaSorin’s LIAISON^® C. Difficile Diagnostic Solution provides accurate and timely detection of C. difficile infection, improving patient outcomes and reducing healthcare costs.

The LIAISON^® Calprotectin assay can be used as an aid in the diagnosis of inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis, and as an aid in the differentiation of IBD from irritable bowel syndrome (IBS).

Chronic pancreatitis can cause maldigestion.  Measuring Pancreatic elastase 1 or fecal elastase 1 (FE-1) in feces allows this condition to be assessed.

Helicobacter pylori is the causative agent of chronic gastritis or inflammation of the stomach lining, duodenal and stomach ulcers, and is associated with an increased risk of stomach cancer. 
Diasorin provides a complete diagnostic solution that include 2 CLIA assays for the detection of antigen and for antibodies for H. pylori.

C. difficile is a major cause of antibiotic-associated diarrhea and colitis. It is the causative agent for most cases of pseudomembranous colitis. These combined tests enable the rapid and efficient diagnosis of Clostridium difficile (C. difficile) infection. DiaSorin’s LIAISON^® C. Difficile Diagnostic Solution provides accurate and timely detection of C. difficile infection, improving patient outcomes and reducing healthcare costs.

The LIAISON^® Calprotectin assay can be used as an aid in the diagnosis of inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis, and as an aid in the differentiation of IBD from irritable bowel syndrome (IBS).

Helicobacter pylori is the causative agent of chronic gastritis or inflammation of the stomach lining, duodenal and stomach ulcers, and is associated with an increased risk of stomach cancer. 
Diasorin provides a complete diagnostic solution that include 2 CLIA assays for the detection of antigen and for antibodies for H. pylori.

Chronic pancreatitis can cause maldigestion.  Measuring Pancreatic elastase 1 or fecal elastase 1 (FE-1) in feces allows this condition to be assessed.

The LIAISON^® Calprotectin assay can be used as an aid in the diagnosis of inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis, and as an aid in the differentiation of IBD from irritable bowel syndrome (IBS).

Chronic pancreatitis can cause maldigestion.  Measuring Pancreatic elastase 1 or fecal elastase 1 (FE-1) in feces allows this condition to be assessed.

C. difficile is a major cause of antibiotic-associated diarrhea and colitis. It is the causative agent for most cases of pseudomembranous colitis. These combined tests enable the rapid and efficient diagnosis of Clostridium difficile (C. difficile) infection. DiaSorin’s LIAISON^® C. Difficile Diagnostic Solution provides accurate and timely detection of C. difficile infection, improving patient outcomes and reducing healthcare costs.

Automated CLIA assay for the qualitative determination of Campylobacter antigens in human stool specimens. The determination of Campylobacter is an aid in the diagnosis of gastrointestinal disorders.

Helicobacter pylori is the causative agent of chronic gastritis or inflammation of the stomach lining, duodenal and stomach ulcers, and is associated with an increased risk of stomach cancer. 
Diasorin provides a complete diagnostic solution that include 2 CLIA assays for the detection of antigen and for antibodies for H. pylori.

C. difficile is a major cause of antibiotic-associated diarrhea and colitis. It is the causative agent for most cases of pseudomembranous colitis. These combined tests enable the rapid and efficient diagnosis of Clostridium difficile (C. difficile) infection. DiaSorin’s LIAISON^® C. Difficile Diagnostic Solution provides accurate and timely detection of C. difficile infection, improving patient outcomes and reducing healthcare costs.